Reset all filters
01 4Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc.
Reset all filters
01 2No Action Indicated
02 2Voluntary Action Indicated
Reset all filters
01 22015-02-06
02 12013-05-17
03 12012-01-20
Reset all filters
01 4South San Francisco
Reset all filters
01 4U.S.A
District Decision : No Action Indicated
Inspection End Date : 2015-02-06
City : South San Francisco
State : California
Country/Area : U.S.A
Zip : 94080
District :
Center :
Project Area : Bioresearch Monitoring
District Decision : No Action Indicated
Inspection End Date : 2015-02-06

District Decision : No Action Indicated
Inspection End Date : 2015-02-06
City : South San Francisco
State : California
Country/Area : U.S.A
Zip : 94080
District :
Center :
Project Area : Drug Quality Assurance
District Decision : No Action Indicated
Inspection End Date : 2015-02-06

District Decision : Voluntary Action Indicated
Inspection End Date : 2013-05-17
City : South San Francisco
State : California
Country/Area : U.S.A
Zip : 94080
District :
Center :
Project Area : Bioresearch Monitoring
District Decision : Voluntary Action Indicated
Inspection End Date : 2013-05-17

District Decision : Voluntary Action Indicated
Inspection End Date : 2012-01-20
City : South San Francisco
State : California
Country/Area : U.S.A
Zip : 94080
District :
Center :
Project Area : Bioresearch Monitoring
District Decision : Voluntary Action Indicated
Inspection End Date : 2012-01-20
